Aerovate Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 13, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	27	14	4	6	3	-
Market Cap Growth	233.80%	233.80%	-28.18%	64.83%	-	-
Enterprise Value	26	12	4	5	2	-
Last Close Price	0.26	0.16	0.08	0.13	-	-
PB Ratio	32.45	16.50	-120.99	6.93	7.50	-
P/TBV Ratio	32.45	16.50	-	6.93	5.61	-
Quick Ratio	6.82	6.82	0.53	9.47	2.27	3.07
Current Ratio	7.11	7.11	0.67	9.75	2.40	3.07
Return on Equity (ROE)	-276.61%	-276.61%	-228.09%	-341.43%	-986.42%	-
Return on Assets (ROA)	-130.33%	-130.33%	-110.30%	-157.72%	-279.55%	-
Return on Capital (ROIC)	-168.42%	-168.42%	-137.91%	-208.14%	-455.61%	-
Earnings Yield	-4.10%	-8.06%	-21.96%	-31.78%	-93.59%	-
Buyback Yield / Dilution	-34.19%	-34.19%	-32.53%	-87.82%	-263.93%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.